The effect of theophylline and caffeine on neuroleptic-induced catalepsy.
D000547:Amantadine / Q000494:pharmacology; D000818:Animals; D001545:Benserazide / Q000494:pharmacology; D002110:Caffeine / Q000494:pharmacology*; D002375:Catalepsy / Q000139:chemically induced / Q000503:physiopathology*; D004357:Drug Synergism; D005260:Female; D005476:Fluphenazine / Q000037:antagonists & inhibitors; D006801:Humans; D007980:Levodopa / Q000494:pharmacology; D051381:Rats; D012110:Reserpine / Q000037:antagonists & inhibitors; D013134:Spiperone / Q000037:antagonists & inhibitors; D013806:Theophylline / Q000494:pharmacology*; D014149:Tranquilizing Agents / Q000494:pharmacology*
D014149:Tranquilizing Agents; D002110:Caffeine; D007980:Levodopa; D013134:Spiperone; D001545:Benserazide; D012110:Reserpine; D000547:Amantadine; D013806:Theophylline; D005476:Fluphenazine